547 related articles for article (PubMed ID: 31081076)
1. Down-regulation of long noncoding RNA DLX6-AS1 defines good prognosis and inhibits proliferation and metastasis in human epithelial ovarian cancer cells via Notch signaling pathway.
Zhao J; Liu HR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3243-3252. PubMed ID: 31081076
[TBL] [Abstract][Full Text] [Related]
2. KCNMA1-AS1 attenuates apoptosis of epithelial ovarian cancer cells and serves as a risk factor for poor prognosis of epithelial ovarian cancer.
Ma SY; Wei P; Qu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4629-4641. PubMed ID: 31210304
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
4. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
Zhuang XH; Liu Y; Li JL
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of lncRNA ASMTL-AS1 in Epithelial Ovarian Cancer Correlates with Worse Prognosis and Cancer Progression.
Xu H; Tang Y; Liu L; Yan J; Qin L
Horm Metab Res; 2022 Jul; 54(7):481-488. PubMed ID: 35835145
[TBL] [Abstract][Full Text] [Related]
7. CKS2 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in epithelial ovarian cancer.
Xu JH; Wang Y; Xu D
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3225-3234. PubMed ID: 31081074
[TBL] [Abstract][Full Text] [Related]
8. HYOU1 promotes cell growth and metastasis via activating PI3K/AKT signaling in epithelial ovarian cancer and predicts poor prognosis.
Li X; Zhang NX; Ye HY; Song PP; Chang W; Chen L; Wang Z; Zhang L; Wang NN
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(10):4126-4135. PubMed ID: 31173282
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TPT1-AS1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT1 expression.
Wu W; Gao H; Li X; Zhu Y; Peng S; Yu J; Zhan G; Wang J; Liu N; Guo X
Cancer Sci; 2019 May; 110(5):1587-1598. PubMed ID: 30941821
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
12. TRIP13 promotes proliferation and invasion of epithelial ovarian cancer cells through Notch signaling pathway.
Zhou XY; Shu XM
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):522-529. PubMed ID: 30720159
[TBL] [Abstract][Full Text] [Related]
13. E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer.
Zhang X; Liu G; Qiu J; Zhang N; Ding J; Hua K
Sci Rep; 2017 Jun; 7(1):4469. PubMed ID: 28667302
[TBL] [Abstract][Full Text] [Related]
14. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of SLP-2 in epithelial ovarian cancer and its regulatory effect on the Notch signaling pathway.
Guo XY; Guo HF; Guo HM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1666-1671. PubMed ID: 32141532
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA GClnc1 knockdown suppresses progression of epithelial ovarian cancer by recruiting FOXC2 to disrupt the NOTCH1/NF-κB/Snail pathway.
Wu D; Ke Y; Xiao R; Liu J; Li Q; Wang Y
Exp Cell Res; 2021 Feb; 399(1):112422. PubMed ID: 33338479
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of long noncoding RNA HMMR-AS1 in epithelial ovarian cancer: an independent prognostic factor.
Chu ZP; Dai J; Jia LG; Li J; Zhang Y; Zhang ZY; Yan P
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8145-8150. PubMed ID: 30556852
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of long noncoding RNA PTPRG-AS1 is associated with poor prognosis in epithelial ovarian cancer.
Ren XY; Yang WB; Tian Y
Rev Assoc Med Bras (1992); 2020 Jul; 66(7):948-953. PubMed ID: 32844927
[TBL] [Abstract][Full Text] [Related]
19. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer.
Liu CN; Zhang HY
J Gene Med; 2020 Oct; 22(10):e3233. PubMed ID: 32449981
[TBL] [Abstract][Full Text] [Related]
20. HOXD-AS1 promotes the epithelial to mesenchymal transition of ovarian cancer cells by regulating miR-186-5p and PIK3R3.
Dong S; Wang R; Wang H; Ding Q; Zhou X; Wang J; Zhang K; Long Y; Lu S; Hong T; Ren H; Wong K; Sheng X; Wang Y; Zeng Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):110. PubMed ID: 30823895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]